13F Holdings
中文EN

HUN Huntsman CORP

Chemicals & Allied Products · NYSE · SEC CIK 1307954 · Fiscal year ends 12/31

Financial factors as of 2026-03-31 (2026Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY-4.7%
TTM net income YoY-111.5%
TTM EPS YoY-112.1%
Revenue 3-yr CAGR-8.5%
Net income 3-yr CAGR—

Margins

Gross margin12.9%
Operating margin-3.3%
Net margin-5.8%
FCF margin2.4%
EBITDA margin1.8%

Returns

ROE-11.8%
ROA-4.6%
ROIC (approx.)-3.3%
Asset turnover0.79x

Leverage & solvency

Liabilities / assets59.3%
Debt / equity0.77x
Current ratio1.27x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.93x
Accruals ratio-8.9%
Payout ratio—
Capex / revenue3.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20242025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$5.68B$6.04B$6.11B$8.02B$7.67B
Cost of revenue$4.93B$5.17B$5.21B$6.48B$6.09B
Gross profit$751.00M$866.00M$906.00M$1.55B$1.58B
R&D expense$120.00M$121.00M$115.00M$125.00M$135.00M
SG&A expense$670.00M$671.00M$689.00M$711.00M$739.00M
Operating income-$131.00M-$25.00M$84.00M$672.00M$731.00M
Pretax income-$192.00M-$39.00M$99.00M$697.00M$1.25B
Income tax$26.00M$61.00M$64.00M$186.00M$191.00M
Net income-$284.00M-$189.00M$101.00M$460.00M$1.04B
EBITDA$156.00M$264.00M$362.00M$953.00M$1.01B
EPS (basic)-1.65-1.100.572.294.77
EPS (diluted)-1.65-1.100.572.274.72
Dividends declared per share0.841.000.950.850.75
Weighted avg. shares (diluted)172.60M172.10M177.40M203.00M221.40M
Balance sheet
Cash & equivalents$429.00M$340.00M$540.00M$654.00M$1.04B
Inventory$818.00M$917.00M$867.00M$995.00M$1.04B
Current assets$2.06B$2.12B$2.31B$3.15B$3.93B
PP&E, net$2.49B$2.49B$2.38B$2.38B$2.44B
Goodwill$630.00M$633.00M$644.00M$641.00M$650.00M
Intangibles$308.00M$344.00M$387.00M$425.00M$469.00M
Total assets$7.01B$7.11B$7.25B$8.22B$9.39B
Current liabilities$1.59B$1.56B$1.17B$1.70B$2.05B
Short-term debt$353.00M$325.00M$12.00M$66.00M$12.00M
Long-term debt$1.66B$1.51B$1.68B$1.67B$1.54B
Total debt$2.01B$1.83B$1.69B$1.74B$1.55B
Total liabilities$4.06B$3.95B$3.77B$4.38B$4.83B
Shareholders' equity$2.75B$2.96B$3.25B$3.62B$4.38B
Net debt$1.58B$1.50B$1.15B$1.08B$509.00M
Shares outstanding172.62M172.14M171.58M183.63M214.17M
Cash flow statement
Operating cash flow$289.00M$263.00M$209.00M$914.00M$952.00M
Capital expenditure$173.00M$184.00M$230.00M$272.00M$326.00M
Free cash flow$116.00M$79.00M-$21.00M$642.00M$626.00M
Investing cash flow-$132.00M-$126.00M$305.00M-$279.00M-$524.00M
Financing cash flow-$76.00M-$326.00M-$620.00M-$994.00M-$977.00M
Depreciation & amortization$287.00M$289.00M$278.00M$281.00M$278.00M
Stock-based compensation$31.00M$30.00M$28.00M$29.00M$30.00M
Dividends paid$146.00M$174.00M$169.00M$171.00M$159.00M
Share buybacks$0$4.00M$349.00M$1.00B$200.00M

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.